Open Demat Account

Aarti Drugs -AARTIDRUGS Share Price

Sector: Pharmaceuticals

₹ 488.60

11.70 (2.45%)

CMPJun 03,2024 12:00 AM

Trade in Aarti Drugs with IIFl Securities! Trade Now

Performance

Aarti Drugs LTD KEY RATIOS

sector: Pharmaceuticals

  • CMP

    -

    -
  • Open
  • ₹ 488.80
  • Prev. Close
  • ₹ 476.90
  • Turnover(Lac.)
  • ₹ 698
  • Day's High
  • ₹ 492.00
  • Day's Low
  • ₹ 477.55
  • 52 Week's High
  • ₹ 645.75
  • 52 Week's Low
  • ₹ 431.05
  • Book Value
  • ₹ 137
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 4,492
  • P/E
  • 31.58
  • EPS
  • 15.43
  • Divi. Yield
  • 0.21

Aarti Drugs LTD PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr. View All Peer Comparison

MORE ABOUT AARTI DRUGS LTD

Summary

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs. It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra. It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign Read More


Reports by Aarti Drugs LTD


Reports by Aarti Drugs LTD

x